Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$506,559
-$67,255 QoQ
Shares Held
71,548
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. GRFS ranks #13 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
|
501,500 | $12,076,120 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $506,559 | 71,548 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $573,814 | 71,548 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $668,973 | 71,548 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $712,618 | 71,548 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $646,793 | 71,548 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $508,706 | 71,548 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $532,317 | 71,548 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $635,346 | 71,548 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $173,834 | 27,549 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $184,027 | 27,549 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,459,586 | 212,767 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,944,690 | 212,767 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,948,945 | 212,767 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,568,092 | 212,767 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,808,519 | 212,767 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,310,644 | 212,767 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,290,071 | 192,767 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,251,518 | 192,767 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $2,262,451 | 201,465 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,943,403 | 201,465 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,495,417 | 201,465 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,718,681 | 215,077 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,909,208 | 320,456 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $5,577,261 | 321,456 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $5,733,342 | 314,328 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,330,565 | 314,328 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||